Trial Profile
A Randomized, Open-label, Two-Period, Two-Crossover Study to Compare the Safety and Pharmacokinetics of Recombinant Human Follicle Stimulating Hormone Injection (LM001) and Gonal-F in Healthy Female Volunteers
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Felbinac ethyl (Primary) ; Follitropin alfa (Primary)
- Indications Female infertility
- Focus Pharmacokinetics
- Sponsors Jiangsu Alphamab Biopharmaceuticals
- 29 May 2018 New trial record